Efficacy, safety, and tolerability of fulranumab, an anti-nerve growth factor antibody, in treatment of patients with moderate-to-severe osteoarthritis pain

Panna Sanga, Nathaniel P. Katz, Elena Polverejan, S. Wang, K. Kelly, Charles Oh, John Thipphawong

Journal of Pain · 2011 · 12 citations · 0 references

No additional data available for this publication yet. Check back later!